Biotech

All Articles

' Clinical intuitiveness' led FDA experts to support Zevra's uncommon disease med

.Zevra Rehabs' unusual ailment medication seems to be to become on the pathway to approval this loss...

Pfizer takes $230M struck after axing neglected DMD gene treatment

.Pfizer's period 3 Duchenne muscle dystrophy (DMD) gene treatment failure has blown a $230 million h...

AC Immune finds 'spots' possible in Alzheimer's medicine information

.After greater than two decades of work on neurodegenerative ailments, Swiss biotech air conditioner...

GSK drops ph. 2 HPV injection over absence of best-in-class potential

.GSK has actually scrapped a phase 2 individual papillomavirus (HPV) injection coming from its own p...

OS Treatments refiles $6M IPO to cash HER2 drug, preclinical ADCs

.Operating system Therapies will definitely list on the NYSE American stock exchange today via a $6....

ALX's waning CD47 reaction price delivers stock spiraling down

.ALX Oncology's period 2 stomach cancer cells action fee has weakened. After seeing its CD47 blocker...

Ionis centers eye condition from aim ats of Roche-partnered possibility after records disappoint

.An Additional of Ionis Pharmaceuticals' crucial midphase readouts has fallen short of assumptions, ...

Biogen's CEO mentioned no risky deals in 2023. He prepares to become daring

.While Biogen's pharma peers are looking for late-stage properties along with little threat, chief e...

Instil refills pipe in $2B biobucks handle ImmunOnco

.Instil Bio has been actually a biotech seeking a pipeline after it ditched its lead possessions ove...

Biogen walks away from Denali Alzheimer's collab

.Biogen has returned legal rights to a very early Alzheimer's disease course to Denali Rehabs, leavi...